Rajendrakumar Jani

Employment

• Independent Subject Expert Advisor
  2016 - Present
• Cadila Healthcare Limited, A Zydus Group Company Snior Vice President
  2001 - 2016
• German Remdies Limited Director
  1994 - 2002
• Rhone Poulenc (India) Limited Manager
  1990 - 1994
• Hoechst Research Center Executive
  1986 - 1990
• Government Medical College Assistant Professor
  1980 - 1986

Education

• Government Medical College Ph.D. (Medical)
  1982 - 1985

Projects & Funding

Projects & funding information is unavailable.

Publications (33)

• Treatment for lipodystrophy
  US20190100492A1 United States 2019
  +Save
• TREATMENT FOR LIPODYSTROPHY
  Patent: Publication number: 20190100492, Filed: May 30, 2018 Publication date: April 4, 2019 2019
  +Save
• TREATMENT FOR LIPODYSTROPHY
  Indian Patent 299505 2018
  +Save
• Treatment for lipodystrophy
  US10017470B2 2018
  +Save
• Novel composition for nonalcoholic fatty liver disease (nafld)
  US20180185330A1 United State 2018
  +Save
• Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers.
  Clinical pharmacokinetics 2018 DOI: 10.1007/s40262-017-0551-3
  +Save
• Composition for nonalcoholic fatty liver disease (NAFLD)
  US9814697B2 United States 2017
  +Save
• Treatment for lipodystrophy
  US9783495B2 United States 2017
  +Save
• A novel composition for nonalcoholic fatty liver disease (nafld)
  EP2988736A1 European Patent Office 2016
  +Save
• A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.
  PloS one 2016 DOI: 10.1371/journal.pone.0146222
  +Save